Cargando…
Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD
OBJECTIVES: To identify the genomic mechanisms that result in PARK2 large gene deletions. METHODS: We conducted mutation screening using PCR amplification of PARK2-coding regions and exon-intron boundaries, followed by sequencing to evaluate a large series of 244 unrelated Portuguese patients with s...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856358/ https://www.ncbi.nlm.nih.gov/pubmed/27182553 http://dx.doi.org/10.1212/NXG.0000000000000073 |
_version_ | 1782430494352211968 |
---|---|
author | Morais, Sara Bastos-Ferreira, Rita Sequeiros, Jorge Alonso, Isabel |
author_facet | Morais, Sara Bastos-Ferreira, Rita Sequeiros, Jorge Alonso, Isabel |
author_sort | Morais, Sara |
collection | PubMed |
description | OBJECTIVES: To identify the genomic mechanisms that result in PARK2 large gene deletions. METHODS: We conducted mutation screening using PCR amplification of PARK2-coding regions and exon-intron boundaries, followed by sequencing to evaluate a large series of 244 unrelated Portuguese patients with symptoms of Parkinson disease. For the detection of large gene rearrangements, we performed multiplex ligation-dependent probe amplification, followed by long-range PCR and sequencing to map deletion breakpoints. RESULTS: We identified biallelic pathogenic parkin mutations in 40 of the 244 patients. There were 18 different mutations, some of them novel. This study included mapping of 17 deletion breakpoints showing that nonhomologous end joining is the most common mechanism responsible for these gene rearrangements. None of these deletion breakpoints were previously described, and only one was present in 2 unrelated families, indicating that most of the deletions result from independent events. CONCLUSIONS: The c.155delA mutation is highly prevalent in the Portuguese population (62.5% of the cases). Large deletions were present in 42.5% of the patients. We present the largest study on the molecular mechanisms that mediate PARK2 deletions in a homogeneous population. |
format | Online Article Text |
id | pubmed-4856358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-48563582016-05-13 Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD Morais, Sara Bastos-Ferreira, Rita Sequeiros, Jorge Alonso, Isabel Neurol Genet Article OBJECTIVES: To identify the genomic mechanisms that result in PARK2 large gene deletions. METHODS: We conducted mutation screening using PCR amplification of PARK2-coding regions and exon-intron boundaries, followed by sequencing to evaluate a large series of 244 unrelated Portuguese patients with symptoms of Parkinson disease. For the detection of large gene rearrangements, we performed multiplex ligation-dependent probe amplification, followed by long-range PCR and sequencing to map deletion breakpoints. RESULTS: We identified biallelic pathogenic parkin mutations in 40 of the 244 patients. There were 18 different mutations, some of them novel. This study included mapping of 17 deletion breakpoints showing that nonhomologous end joining is the most common mechanism responsible for these gene rearrangements. None of these deletion breakpoints were previously described, and only one was present in 2 unrelated families, indicating that most of the deletions result from independent events. CONCLUSIONS: The c.155delA mutation is highly prevalent in the Portuguese population (62.5% of the cases). Large deletions were present in 42.5% of the patients. We present the largest study on the molecular mechanisms that mediate PARK2 deletions in a homogeneous population. Wolters Kluwer 2016-05-03 /pmc/articles/PMC4856358/ /pubmed/27182553 http://dx.doi.org/10.1212/NXG.0000000000000073 Text en © 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Article Morais, Sara Bastos-Ferreira, Rita Sequeiros, Jorge Alonso, Isabel Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD |
title | Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD |
title_full | Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD |
title_fullStr | Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD |
title_full_unstemmed | Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD |
title_short | Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD |
title_sort | genomic mechanisms underlying park2 large deletions identified in a cohort of patients with pd |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856358/ https://www.ncbi.nlm.nih.gov/pubmed/27182553 http://dx.doi.org/10.1212/NXG.0000000000000073 |
work_keys_str_mv | AT moraissara genomicmechanismsunderlyingpark2largedeletionsidentifiedinacohortofpatientswithpd AT bastosferreirarita genomicmechanismsunderlyingpark2largedeletionsidentifiedinacohortofpatientswithpd AT sequeirosjorge genomicmechanismsunderlyingpark2largedeletionsidentifiedinacohortofpatientswithpd AT alonsoisabel genomicmechanismsunderlyingpark2largedeletionsidentifiedinacohortofpatientswithpd |